Menu
Back to User profile » Prof. Dr. Sooyoung Shin
Papers published by Prof. Dr. Sooyoung Shin:
Clinical Benefits of Oral Anticoagulant Use in Cancer Patients at Increased Risk for Venous Thromboembolism per Khorana Index
Choi YJ, Choi YW, Chae J, Yun H, Shin S
Risk Management and Healthcare Policy 2021, 14:1855-1867
Published Date: 7 May 2021
Vancomycin Dosage and Its Association with Clinical Outcomes in Pediatric Patients with Gram-Positive Bacterial Infections
Shin S, Jung HJ, Jeon SM, Park YJ, Chae JW, Yun HY
Risk Management and Healthcare Policy 2020, 13:685-695
Published Date: 29 June 2020
Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
Choi YJ, Kim DJ, Shin S
Cancer Management and Research 2019, 11:7427-7438
Published Date: 6 August 2019
Safety of celecoxib versus traditional nonsteroidal anti-inflammatory drugs in older patients with arthritis
Shin S
Journal of Pain Research 2018, 11:3211-3219
Published Date: 14 December 2018
Durability of initial antidiabetic monotherapy and subsequent treatment adjustment patterns among newly treated type 2 diabetes patients
Noh Y, Lee S, Shin S
Therapeutics and Clinical Risk Management 2018, 14:1563-1571
Published Date: 3 September 2018
Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials
Shin S, Noh Y
Therapeutics and Clinical Risk Management 2018, 14:833-847
Published Date: 4 May 2018
Drug utilization and therapy provision patterns by prescriber types among patients with systemic lupus erythematosus in Korea
Shin S
Patient Preference and Adherence 2017, 11:1779-1787
Published Date: 17 October 2017
Impact of statins on risk of new onset diabetes mellitus: a population-based cohort study using the Korean National Health Insurance claims database
Lee J, Noh Y, Shin S, Lim H, Park RW, Bae SK, Oh E, Kim GJ, Kim JH, Lee S
Therapeutics and Clinical Risk Management 2016, 12:1533-1543
Published Date: 11 October 2016
The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort study
Shin S, Kim H
Therapeutics and Clinical Risk Management 2016, 12:435-444
Published Date: 15 March 2016
Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review
Shin S
Therapeutics and Clinical Risk Management 2015, 11:649-657
Published Date: 24 April 2015
Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
Shin S, Lee S
Therapeutics and Clinical Risk Management 2014, 10:875-883
Published Date: 14 October 2014